Annual CFI
-$4.85 M
-$96.33 M-105.30%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual cash flow from investing activities is -$4.85 million, with the most recent change of -$96.33 million (-105.30%) on December 31, 2023.
- During the last 3 years, OLMA annual CFI has fallen by -$4.79 million (-8562.50%).
- OLMA annual CFI is now -105.30% below its all-time high of $91.48 million, reached on December 31, 2022.
Performance
OLMA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$45.92 M
+$50.80 M+1041.37%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly cash flow from investing activities is $45.92 million, with the most recent change of +$50.80 million (+1041.37%) on September 30, 2024.
- Over the past year, OLMA quarterly CFI has increased by +$71.36 million (+280.53%).
- OLMA quarterly CFI is now at all-time high.
Performance
OLMA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$10.02 M
+$71.36 M+87.69%
September 30, 2024
Summary
- As of February 7, 2025, OLMA TTM cash flow from investing activities is -$10.02 million, with the most recent change of +$71.36 million (+87.69%) on September 30, 2024.
- Over the past year, OLMA TTM CFI has dropped by -$52.42 million (-123.62%).
- OLMA TTM CFI is now -109.70% below its all-time high of $103.30 million, reached on March 31, 2023.
Performance
OLMA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OLMA Cash From Investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -105.3% | +280.5% | -123.6% |
3 y3 years | -8562.5% | +280.5% | -123.6% |
5 y5 years | -100.0% | +280.5% | -123.6% |
OLMA Cash From Investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -105.3% | +98.2% | at high | +248.5% | -109.7% | +96.4% |
5 y | 5-year | -105.3% | +98.2% | at high | +116.4% | -109.7% | +96.4% |
alltime | all time | -105.3% | +98.2% | at high | +116.4% | -109.7% | +96.4% |
Olema Pharmaceuticals Cash From Investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $45.92 M(-1041.4%) | -$10.02 M(-87.7%) |
Jun 2024 | - | -$4.88 M(-75.8%) | -$81.37 M(+30.4%) |
Mar 2024 | - | -$20.14 M(-34.8%) | -$62.38 M(+1186.0%) |
Dec 2023 | -$4.85 M(-105.3%) | -$30.91 M(+21.5%) | -$4.85 M(-111.4%) |
Sep 2023 | - | -$25.44 M(-280.2%) | $42.40 M(-51.8%) |
Jun 2023 | - | $14.11 M(-62.3%) | $88.00 M(-14.8%) |
Mar 2023 | - | $37.39 M(+128.9%) | $103.30 M(+12.9%) |
Dec 2022 | $91.48 M(-133.2%) | $16.34 M(-19.0%) | $91.48 M(+12.7%) |
Sep 2022 | - | $20.16 M(-31.4%) | $81.14 M(+68.4%) |
Jun 2022 | - | $29.41 M(+15.0%) | $48.20 M(+62.2%) |
Mar 2022 | - | $25.57 M(+326.1%) | $29.71 M(-110.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$275.44 M(>+9900.0%) | $6.00 M(-146.9%) | -$275.44 M(-2.1%) |
Sep 2021 | - | -$12.78 M(-217.0%) | -$281.49 M(+4.8%) |
Jun 2021 | - | $10.93 M(-103.9%) | -$268.69 M(-3.9%) |
Mar 2021 | - | -$279.58 M(>+9900.0%) | -$279.63 M(>+9900.0%) |
Dec 2020 | -$56.00 K(<-9900.0%) | -$51.00 K(-610.0%) | -$56.00 K(+1020.0%) |
Sep 2020 | - | $10.00 K(-266.7%) | -$5000.00(-66.7%) |
Jun 2020 | - | -$6000.00(-33.3%) | -$15.00 K(+66.7%) |
Mar 2020 | - | -$9000.00(<-9900.0%) | -$9000.00(<-9900.0%) |
Dec 2019 | $0.00(0.0%) | - | - |
Sep 2019 | - | $0.00 | $0.00 |
Dec 2018 | $0.00 | - | - |
FAQ
- What is Olema Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual CFI year-on-year change?
- What is Olema Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly CFI year-on-year change?
- What is Olema Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals TTM CFI year-on-year change?
What is Olema Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of OLMA is -$4.85 M
What is the all time high annual CFI for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual cash flow from investing activities is $91.48 M
What is Olema Pharmaceuticals annual CFI year-on-year change?
Over the past year, OLMA annual cash flow from investing activities has changed by -$96.33 M (-105.30%)
What is Olema Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of OLMA is $45.92 M
What is the all time high quarterly CFI for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly cash flow from investing activities is $45.92 M
What is Olema Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, OLMA quarterly cash flow from investing activities has changed by +$71.36 M (+280.53%)
What is Olema Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of OLMA is -$10.02 M
What is the all time high TTM CFI for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high TTM cash flow from investing activities is $103.30 M
What is Olema Pharmaceuticals TTM CFI year-on-year change?
Over the past year, OLMA TTM cash flow from investing activities has changed by -$52.42 M (-123.62%)